The long term objective of this application is to identify the pathophysiologic mechanisms implicated in myocyte cell death and reactive cellular growth processes which underlie the evolution of the cardiomyopathic heart of ischemic origin. Our principal working hypothesis is that sudden reductions in coronary artery luminal diameter impair ventricular function, resulting in diastolic Laplace overload, mechanical myocyte cell death and mural cell slippage, which are the major determinants of acute chamber dilation and thinning of the wall with ischemia. On the other hand, chronic ventricular remodeling is postulated to be dependent upon changes in number and size of myocytes which dictate the progression of the disease towards congestive heart failure. This anatomical-functional condition is brought about through abnormal increases in pressure and volume loads on the myocardium which are not normalized by compensatory growth mechanisms of the myocyte compartment of the tissue. The combination of these events is expected to lead to a reduction in ventricular mass-to-chamber volume ration and severe depression in cardiac pump performance which characterize decompensated eccentric ventricular hypertrophy. On this basis, the hypothesis is advanced that long-term ventricular dilation is the product of increases in myocyte length, without a proportionate expansion in myocyte diameter, and the in series addition of newly formed muscle cells by myocyte mitotic division. Therefore, it becomes relevant to determine whether differences in the nature and magnitude of the loading state on myocytes selectively activate specific surface receptors which may be coupled with increases in cell length, cell diameter and cell number. It is proposed that activation of surface alpha-adrenergic receptors mediates the lengthening of myocytes, whereas surface angiotensin II receptors are involved in the lateral expansion of these cells. Moreover, the expression and activation of the myocyte IGF, autocrine system is believed to be associated with induction of late growth related genes, DNA synthesis, nuclear mitotic division and myocyte proliferation. In conclusion, the recognition of the molecular control mechanisms of myocyte cellular hypertrophy and hyperplasia and their temporal sequence may provide new strategies to interrupt or direct these adaptive growth responses which condition the final dimensions of the heart. The benefits of such an approach may be seen in the possibility of modulating myocyte growth and consequently ventricular dilation, which ultimately determines end-stage cardiac failure.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL038132-06A3
Application #
2218707
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1987-08-01
Project End
2000-01-31
Budget Start
1995-02-01
Budget End
1996-01-31
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
New York Medical College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Signore, Sergio; Sorrentino, Andrea; Ferreira-Martins, João et al. (2014) Response to letter regarding article ""Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes"". Circulation 129:e510-1
Anversa, Piero; Leri, Annarosa; Rota, Marcello et al. (2007) Concise review: stem cells, myocardial regeneration, and methodological artifacts. Stem Cells 25:589-601
Kajstura, Jan; Rota, Marcello; Urbanek, Konrad et al. (2006) The telomere-telomerase axis and the heart. Antioxid Redox Signal 8:2125-41
Kajstura, Jan; Bolli, Roberto; Sonnenblick, Edmund H et al. (2006) Cause of death: suicide. J Mol Cell Cardiol 40:425-37
Anversa, Piero; Leri, Annarosa; Kajstura, Jan (2006) Cardiac regeneration. J Am Coll Cardiol 47:1769-76
Rota, Marcello; LeCapitaine, Nicole; Hosoda, Toru et al. (2006) Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 99:42-52
Urbanek, Konrad; Torella, Daniele; Sheikh, Farooq et al. (2005) Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A 102:8692-7
Kajstura, Jan; Rota, Marcello; Whang, Brian et al. (2005) Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96:127-37
Anversa, Piero; Rota, Marcello; Urbanek, Konrad et al. (2005) Myocardial aging--a stem cell problem. Basic Res Cardiol 100:482-93
Linke, Axel; Muller, Patrick; Nurzynska, Daria et al. (2005) Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 102:8966-71

Showing the most recent 10 out of 167 publications